Diabetology & Metabolic Syndrome,
Год журнала:
2024,
Номер
16(1)
Опубликована: Фев. 15, 2024
Cannabinoid
receptors
are
components
of
the
endocannabinoid
system
that
affect
various
physiological
functions.
We
aim
to
investigate
effect
cannabinoid
receptor
modulation
on
kidney
disease.
PubMed,
Web
Science
databases,
and
EMBASE
were
searched.
Articles
selection,
data
extraction
quality
assessment
independently
performed
by
two
investigators.
The
SYRCLE's
RoB
tool
was
used
assess
risk
study
bias,
pooled
SMD
using
a
random-effect
model
95%
CIs
calculated.
Subgroup
analyses
conducted
in
preselected
subgroups,
publication
bias
evaluated.
compared
effects
CB1
CB2
antagonists
and/or
knockout
agonists
genetic
regulation
renal
function,
blood
glucose
levels,
body
weight,
pathological
damage-related
indicators
different
models
chronic
acute
injury.
blockade
or
could
significantly
reduce
urea
nitrogen
[SMD,-
1.67
(95%
CI
-
2.27
1.07)],
serum
creatinine
[SMD,
1.88
2.91
0.85)],
albuminuria
1.60
2.16
1.04)]
dysfunction
animals
with
control
group.
activation
group
0.97
1.83
0.11)]
2.43
4.63
0.23)]
results
suggest
targeting
receptors,
particularly
agonists,
can
improve
function
inflammatory
responses,
exerting
protective
maintaining
therapeutic
potential
types
Physiological Reviews,
Год журнала:
2016,
Номер
96(4), С. 1593 - 1659
Опубликована: Сен. 15, 2016
Apart
from
having
been
used
and
misused
for
at
least
four
millennia
for,
among
others,
recreational
medicinal
purposes,
the
cannabis
plant
its
most
peculiar
chemical
components,
cannabinoids
(phytocannabinoids),
have
merit
to
led
humanity
discover
one
of
intriguing
pleiotropic
endogenous
signaling
systems,
endocannabinoid
system
(ECS).
This
review
article
aims
describe
critically
discuss,
in
comprehensive
possible
manner,
multifaceted
aspects
1)
pharmacology
potential
impact
on
mammalian
physiology
all
major
phytocannabinoids,
not
only
famous
Δ
9
-tetrahydrocannabinol,
2)
adaptive
pro-homeostatic
physiological,
or
maladaptive
pathological,
roles
ECS
cells,
tissues,
organs.
In
doing
so,
we
respected
chronological
order
milestones
millennial
route
medicinal/recreational
beyond,
as
it
is
now
clear
that
some
early
steps
this
long
path,
which
were
originally
neglected,
are
becoming
important
again.
The
emerging
picture
rather
complex,
but
still
supports
belief
more
discoveries
human
physiology,
new
therapies,
might
come
future
knowledge
field.
Clinical Science,
Год журнала:
2022,
Номер
136(7), С. 493 - 520
Опубликована: Апрель 1, 2022
Abstract
Albuminuria
is
the
hallmark
of
both
primary
and
secondary
proteinuric
glomerulopathies,
including
focal
segmental
glomerulosclerosis
(FSGS),
obesity-related
nephropathy,
diabetic
nephropathy
(DN).
Moreover,
albuminuria
an
important
feature
all
chronic
kidney
diseases
(CKDs).
Podocytes
play
a
key
role
in
maintaining
permselectivity
glomerular
filtration
barrier
(GFB)
injury
podocyte,
leading
to
foot
process
(FP)
effacement
podocyte
loss,
unifying
underlying
mechanism
glomerulopathies.
The
metabolic
insult
hyperglycemia
paramount
importance
pathogenesis
DN,
while
insults
damage
are
poorly
defined
other
However,
shared
mechanisms
have
been
identified.
Herein,
we
will
review
haemodynamic
oxidative
stress,
inflammation,
lipotoxicity,
endocannabinoid
(EC)
hypertone,
mitochondrial
autophagic
dysfunction
damage,
focussing
particularly
on
their
DN.
Gaining
better
insight
into
may
provide
novel
targets
for
treatment.
strategies
boosting
repair
open
way
regenerative
medicine.
Pharmacological Reviews,
Год журнала:
2023,
Номер
75(5), С. 885 - 958
Опубликована: Май 10, 2023
The
cannabis
derivative
marijuana
is
the
most
widely
used
recreational
drug
in
Western
world
and
consumed
by
an
estimated
83
million
individuals
(∼3%
of
population).
In
recent
years,
there
has
been
a
marked
transformation
society
regarding
risk
perception
cannabis,
driven
its
legalization
medical
use
many
states
United
States
worldwide.
Compelling
research
evidence
Food
Drug
Administration
cannabis-derived
cannabidiol
approval
for
severe
childhood
epilepsy
have
confirmed
large
therapeutic
potential
itself,
Δ
British Journal of Pharmacology,
Год журнала:
2015,
Номер
173(7), С. 1116 - 1127
Опубликована: Июнь 16, 2015
Increasing
evidence
suggests
that
an
overactive
endocannabinoid
system
(ECS)
may
contribute
to
the
development
of
diabetes
by
promoting
energy
intake
and
storage,
impairing
both
glucose
lipid
metabolism,
exerting
pro-apoptotic
effects
in
pancreatic
beta
cells
facilitating
inflammation
islets.
Furthermore,
hyperglycaemia
associated
with
has
also
been
implicated
triggering
perturbations
ECS
amplifying
pathological
processes
mentioned
above,
eventually
culminating
a
vicious
circle.
Compelling
from
preclinical
studies
indicates
influences
diabetes-induced
oxidative
stress,
inflammation,
fibrosis
subsequent
tissue
injury
target
organs
for
diabetic
complications.
In
this
review,
we
provide
update
on
contribution
pathogenesis
microvascular
(retinopathy,
nephropathy
neuropathy)
cardiovascular
The
therapeutic
potential
targeting
is
discussed.This
article
part
themed
section
Endocannabinoids.
To
view
other
articles
visit
http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.7/issuetoc.
Pharmacology & Therapeutics,
Год журнала:
2020,
Номер
208, С. 107477 - 107477
Опубликована: Янв. 9, 2020
Endocannabinoids
acting
via
CB1
receptors
(CB1R)
play
a
critical
role
in
regulating
energy
homeostasis,
which
was
the
rationale
for
pharmaceutical
development
of
CB1R
antagonists
treatment
obesity.
Although
first-in-class
antagonist
rimonabant
proved
to
be
effective
mitigating
obesity
and
its
multiple
cardiometabolic
complications,
it
withdrawn
from
clinical
use
due
CNS-mediated
neuropsychiatric
side
effects,
halted
further
therapeutic
whole
class
these
compounds.
Compared
brain,
CB1Rs
are
expressed
at
low
yet
functional
levels
peripheral
organs
involved
including
liver,
skeletal
muscle,
adipose
tissue
endocrine
pancreas.
In
recent
preclinical
studies,
selective
targeting
by
'second
generation'
peripherally
restricted
replicated
metabolic
benefits
rodent
models
diabetes
without
causing
effects.
Increased
activity
also
contributes
complex,
multifactorial
disorders
such
as
various
forms
fibrosis,
may
benefit
simultaneous
engagement
more
than
one
target.
Accordingly,
novel
'third
hybrid
inhibitors
inducible
NO
synthase
were
tested
mouse
liver
pulmonary
fibrosis
where
their
antifibrotic
efficacy
found
exceed
drugs
that
inhibit
only
targets.
this
review,
we
will
discuss
challenges
opportunities
offered
second
third
generation
potential
uses.
Antioxidants and Redox Signaling,
Год журнала:
2017,
Номер
29(1), С. 75 - 108
Опубликована: Май 12, 2017
Significance:
Redox
imbalance
may
lead
to
overproduction
of
reactive
oxygen
and
nitrogen
species
(ROS/RNS)
subsequent
oxidative
tissue
damage,
which
is
a
critical
event
in
the
course
neurodegenerative
diseases.
It
still
not
fully
elucidated,
however,
whether
stress
primary
trigger
or
consequence
process
neurodegeneration.
Recent
Advances:
Increasing
evidence
suggests
that
involved
propagation
neuronal
injury
consequent
inflammatory
response,
concert
promote
development
pathological
alterations
characteristic
most
common
Critical
Issues:
Accumulating
recent
also
there
an
important
interplay
between
lipid
endocannabinoid
system
[ECS;
comprising
main
cannabinoid
1
2
receptors
(CB1
CB2),
endocannabinoids,
their
synthetic
metabolizing
enzymes]
various
key
redox-dependent
processes.
Future
Directions:
Targeting
ECS
modulate
redox
state-dependent
cell
death
decrease
preceding
response
holds
therapeutic
potential
multitude
stress-related
acute
chronic
disorders
from
stroke
traumatic
brain
Alzheimer's
Parkinson's
diseases
multiple
sclerosis,
just
name
few,
will
be
discussed
this
overview.
Antioxid.
Signal.
29,
75–108.
Pharmacological Reviews,
Год журнала:
2017,
Номер
70(1), С. 39 - 67
Опубликована: Дек. 12, 2017
G
protein–coupled
receptors
(GPCRs)
continue
to
be
important
discovery
targets
for
the
treatment
of
type
2
diabetes
mellitus
(T2DM).
Many
GPCRs
are
directly
involved
in
development
insulin
resistance
and
β-cell
dysfunction,
etiology
inflammation
that
can
lead
obesity-induced
T2DM.
This
review
summarizes
current
literature
describing
a
number
well-validated
GPCR
targets,
but
also
outlines
several
new
promising
drug
discovery.
We
highlight
importance
understanding
role
these
disease
pathology,
their
basic
pharmacology,
which
will
pave
way
novel
pharmacological
probes
enable
fulfill
promise
metabolic
disorders.